ArticleCureus2025
Multisystem Embolic Events From Prosthetic Mitral Valve Endocarditis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prosthetic valve endocarditis (PVE) is a severe form of infective endocarditis, associated with high morbidity, mortality, and frequent embolic complications. Embolic events are among its most severe complications, potentially involving major organs such as the brain, spleen, kidneys, and lungs. We report herein the case of a 58-year-old woman with a mechanical mitral valve who presented with fever, constitutional symptoms, and subsequent acute right-sided hemiparesis and dysarthria. Transthoracic and transesophageal echocardiography revealed a large, mobile vegetation on the prosthetic mitral valve. Imaging confirmed multiple systemic emboli involving the spleen, right kidney, and superior mesenteric artery. Blood cultures, including fungal studies, were repeatedly negative, but the diagnosis of PVE was established using the modified Duke criteria. Our patient received empiric intravenous antibiotherapy, resulting in clinical improvement and a reduction in inflammatory markers. Despite favorable medical response, the presence of a large vegetation and multiple embolic events warranted urgent surgical reassessment. The rarity of this case lies in the occurrence of multiple embolic sites during the same episode of endocarditis. It underscores the aggressive nature of PVE, its propensity for multisystemic embolic events, and the critical importance of early diagnosis to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.